Service

IAC Nuclear/PET and Radiopharmaceutical Therapy Accreditation Consulting

IAC Nuclear/PET accreditation is the Intersocietal Accreditation Commission's program for nuclear cardiology, general nuclear medicine, PET and radiopharmaceutical therapy facilities, measured against the IAC Standards & Guidelines for Nuclear/PET Accreditation (version IAC lists as published April 1, 2025) and, for therapy, IAC's separate Radiopharmaceutical Therapy standards. This page is for nuclear medicine, PET and radiopharmaceutical therapy program managers seeking accreditation, adding a modality or expanding therapy services. Integral Healthcare Solutions (IHS) drafts the program's policies and evidence file for IAC nuclear accreditation; your physicians and radiation safety officer own protocols and safety.

Last reviewed: October 2026.

What is IAC Nuclear/PET accreditation?

IAC offers Nuclear/PET accreditation to facilities that perform nuclear cardiology, general nuclear medicine and PET imaging (IAC, Nuclear/PET, page opened October 3, 2026). IAC lists four accreditation types: Nuclear Cardiology, General Nuclear Medicine, Positron Emission Tomography (PET) and Radiopharmaceutical Therapy.

The governing texts:

Accreditation sits on top of a license, not in place of one. Federal rule 10 CFR 35.11(a) states that a person may "manufacture, produce, acquire, receive, possess, prepare, use, or transfer byproduct material for medical use only in accordance with a specific license issued by the Commission or an Agreement State." NRC states that it "(or the responsible Agreement State) has regulatory authority over the possession and use of byproduct, source, or special nuclear material in medicine" (NRC, Medical Uses).

Who needs it and what triggers it

How IHS helps

IHS works through the IAC standards with your team:

  1. A gap assessment against the IAC Nuclear/PET standards, and the radiopharmaceutical therapy standards when therapy is in scope, using questionnaires on authorized users, safety roles and quality improvement review.
  2. Document and evidence mapping: a crosswalk from each checklist item to the record that shows you meet it.
  3. Drafted policies, document control and QI review procedures, with clinical and stress protocols drafted for your physicians and radiation safety officer to review and approve.
  4. A mock review of the application file against the standards and checklist.
  5. Readiness support while you assemble case studies and respond to IAC.

What you supply: the IAC standards, your radioactive materials license, authorized-user records, QC and maintenance records, and your nuclear medicine physicians, physicists and radiation safety officer.

The limit: radiation safety, materials control and therapy dosing are licensed functions. IHS does not perform them, and therapy adds separate scope. Your facility holds the license and submits the application; IHS does not submit to IAC or correspond with IAC or a licensing agency on your behalf.

What to have ready

This is the list we would ask for first. Items cite the IAC Nuclear/PET Accreditation Checklist (updated 3-15-2026) unless noted.

Printable version of this checklist (PDF)

How it compares

RouteWhat the sources say
IAC Nuclear/PETFour types, including radiopharmaceutical therapy (IAC). A CMS-approved accrediting organization for advanced diagnostic imaging (CMS). IAC puts application review at roughly 8 to 10 weeks (IAC, page opened October 3, 2026).
ACR Nuclear Medicine & PETListed among ACR's accreditation modalities (ACR) and a CMS-approved ADI accrediting organization (CMS).
The Joint Commission or RadSiteBoth are CMS-approved ADI accrediting organizations (CMS). We did not review nuclear-specific program pages for either.
No accreditationHospitals and critical access hospitals are outside the MIPPA ADI requirement (CMS). The radioactive materials license is required regardless (10 CFR 35.11).

This page does not recommend one route over another. The choice belongs to your organization.

What it costs

IAC publishes its Nuclear/PET fees on its program-fees page: $3,800 for the application base fee, which includes one testing area, and $500 for each additional testing area. Radiopharmaceutical Therapy is $4,000 for up to three therapy procedures and $6,000 for four or more. An expedited application adds $3,000. IAC says the fees cover one three-year accreditation cycle (IAC Nuclear/PET program fees, page opened October 3, 2026). ACR’s fee article lists $2,300 for the first Nuclear Medicine unit with one module and $2,300 for the first PET unit with one module (ACR, Fees and Payments, page opened October 3, 2026). Verify current fees with IAC and ACR. NRC and Agreement State license fees were not part of our review.

Our IAC fee guide and ACR fee guide lay out each body's full schedule.

IHS scopes each engagement after a free introductory call.

What this is not

Frequently asked questions

What is IAC Nuclear/PET accreditation, and which testing areas does it cover?

IAC offers it to facilities that perform nuclear cardiology, general nuclear medicine and PET imaging. It covers four types: Nuclear Cardiology, General Nuclear Medicine, PET and Radiopharmaceutical Therapy. The governing text is the IAC Standards & Guidelines for Nuclear/PET Accreditation, which IAC’s standards page lists as published April 1, 2025.

Does a nuclear cardiology practice need accreditation to bill Medicare for SPECT or PET?

CMS lists nuclear medicine imaging, such as PET, as advanced diagnostic imaging and states that any supplier that performs the technical component of ADI must be accredited. The requirement does not apply to hospitals or critical access hospitals. CMS-approved accrediting organizations are ACR, IAC, The Joint Commission and RadSite.

IAC vs ACR for nuclear medicine and PET accreditation: which fits a cardiology practice?

Both are CMS-approved accrediting organizations for advanced diagnostic imaging, and both list nuclear medicine and PET. IAC also offers Nuclear Cardiology and Radiopharmaceutical Therapy as named types. The choice belongs to your practice; IHS works to whichever route you select.

What is IAC radiopharmaceutical therapy accreditation?

It is a separate IAC accreditation type with its own standard. That standard sets a qualified Medical Director and a Technical Director as the minimum staffing of a therapy facility. The IAC standards page and the PDF text show different dates, so confirm the current version with IAC.

What documents does IAC require for a nuclear/PET application?

The 2026 IAC checklist includes the NRC or Agreement State radioactive materials license for each site, CME/CE records, minutes of at least two QI meetings per year, semiannual preventive maintenance documentation, and case studies. The checklist was updated March 15, 2026.

How do the NRC or Agreement State materials license and accreditation relate?

They are separate. Under 10 CFR 35.11(a), medical use of byproduct material requires a specific license issued by NRC or an Agreement State, whether or not the facility is accredited. IAC's checklist asks for that license for each site listed on the application.

Who appoints the radiation safety officer?

Under 10 CFR 35.24(b), the licensee's management appoints a Radiation Safety Officer who agrees, in writing, to be responsible for implementing the radiation protection program. IHS can draft the program's documents around that role; the radiation safety work itself belongs to the RSO.

How much does IAC nuclear/PET accreditation cost, including therapy?

IAC publishes a $3,800 application base fee that includes one testing area, $500 per additional testing area, and $4,000 or $6,000 for radiopharmaceutical therapy depending on the number of therapy procedures. An expedited application adds $3,000, and the fees cover one three-year cycle. Verify current fees with IAC.

How many case studies are needed and how recent must they be?

IAC’s checklist limits case studies to the year before the application submission date and requires at least one to be interpreted by the Medical Director.

How long does IAC review take?

IAC says an application review generally runs about 8 to 10 weeks before the facility receives a decision. The time your team needs to assemble the file comes before that.

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session